Design, synthesis and anticancer activity of novel 2-arylbenzimidazole/2-thiopyrimidines and 2-thioquinazolin-4(3H)-ones conjugates as targeted RAF and VEGFR-2 kinases inhibitors
- Resource Type
- Article
- Source
- In
Bioorganic Chemistry September 2022 126 - Subject
- Language
- ISSN
- 0045-2068